Ameritas Investment Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-36,911
| Closed | -$39.5K | – | 3042 |
|
|
2022
Q4 | $39.5K | Buy |
36,911
+8,396
| +29% | +$8.98K | ﹤0.01% | 2219 |
|
|
2022
Q3 | $44K | Hold |
28,515
| – | – | ﹤0.01% | 2078 |
|
|
2022
Q2 | $57K | Buy |
28,515
+5,426
| +24% | +$10.8K | ﹤0.01% | 1913 |
|
|
2022
Q1 | $54K | Hold |
23,089
| – | – | ﹤0.01% | 2025 |
|
|
2021
Q4 | $107K | Buy |
23,089
+2,123
| +10% | +$9.84K | ﹤0.01% | 1639 |
|
|
2021
Q3 | $160K | Hold |
20,966
| – | – | 0.01% | 1379 |
|
|
2021
Q2 | $203K | Hold |
20,966
| – | – | 0.01% | 1241 |
|
|
2021
Q1 | $173K | Hold |
20,966
| – | – | 0.01% | 1314 |
|
|
2020
Q4 | $143K | Buy |
20,966
+2,104
| +11% | +$14.4K | 0.01% | 1347 |
|
|
2020
Q3 | $210K | Buy |
18,862
+3,371
| +22% | +$37.5K | 0.01% | 1009 |
|
|
2020
Q2 | $97K | Buy |
15,491
+6,016
| +63% | +$37.7K | ﹤0.01% | 1437 |
|
|
2020
Q1 | $17K | Hold |
9,475
| – | – | ﹤0.01% | 2274 |
|
|
2019
Q4 | $32K | Hold |
9,475
| – | – | ﹤0.01% | 2165 |
|
|
2019
Q3 | $20K | Hold |
9,475
| – | – | ﹤0.01% | 2401 |
|
|
2019
Q2 | $25K | Buy |
9,475
+2,230
| +31% | +$5.88K | ﹤0.01% | 2330 |
|
|
2019
Q1 | $34K | Hold |
7,245
| – | – | ﹤0.01% | 2095 |
|
|
2018
Q4 | $17K | Hold |
7,245
| – | – | ﹤0.01% | 2446 |
|
|
2018
Q3 | $32K | Hold |
7,245
| – | – | ﹤0.01% | 2254 |
|
|
2018
Q2 | $52K | Buy |
+7,245
| New | +$52K | ﹤0.01% | 1970 |
|
|
2017
Q2 | – | Sell |
-2,189
| Closed | -$9K | – | 3073 |
|
|
2017
Q1 | $9K | Buy |
+2,189
| New | +$9K | ﹤0.01% | 2740 |
|